Hematology/Oncology

Top Story

Surgeon’s proficiency in esophagectomy affects short- and long-term cancer outcomes

May 26, 2016

Undergoing esophagectomy with a surgeon who had performed at least 15 surgeries reduced short-term mortality among patients with esophageal cancer, according to results of a population-based, nationwide Swedish cohort study.

Further, patients’ long-term mortality improved after surgeons had performed 59 or more surgeries, results showed.

Meeting News Coverage

Top Takeaways from ASH: Benefits, drawbacks of Factor VIII products require discussion with patients

May 26, 2016
The multicenter, randomized Survey of Inhibitors in Plasma-Product Exposed Toddlers, or SIPPET study, presented at the ASH Annual Meeting and Exposition, which…
FDA News

FDA approves Afstyla to treat patients with hemophilia A

May 26, 2016
The FDA approved antihemophilic factor (recombinant), single chain to treat adults and children with hemophilia A.Antihemophilic factor (recombinant), single chain…
Ask the Experts

What is a cyst?

May 26, 2016
A cyst is a closed sac with a defined membrane and division on the nearby tissue. Cysts may contain fluid, air or semi-solid material. There are various types of…
In the Journals

Physical activity associated with lower risks of 13 cancers

May 26, 2016
Leisure-time physical activity was associated with lower risks for 13 out of 26 cancers included in an investigation published in JAMA Internal Medicine. Steven C
More News Headlines »
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Video
Meeting News Coverage

VIDEO: Expert discusses controversies in lung cancer screenings

May 13, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan